Clinical Trial Update: Evaluation of CPP-ACP Prophylactic Effect on Enamel Surface During Orthodontic Treatment [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluates CPP-ACP (casein phosphopeptide-amorphous calcium phosphate) for prophylaxis of enamel surface demineralization during orthodont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enamel Hypomineralization
• White Spot Lesion

Drugs mentioned

• CPP-ACP (Casein phosphopeptide-amorphous calcium phosphate)

Snippet

Sponsor: Cairo University | Conditions: White Spot Lesion, Enamel Hypomineralization | Phase 1 | Status: UNKNOWN